About this trial
retrospective and prospective multicenter observational clinical and biological data collection from all patients with newly diagnosed CLL, SLL or MBL.
retrospective cohort: all cases with a diagnosis between January 1st 2010 and August 31th 2021.
prospective cohort: all patients with a diagnosis between September 1st 2021 and September 1st 2025.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years at diagnosis
One of the following diagnoses that meet the international diagnostic criteria (iwCLL2018 and WHO2017)
Chronic lymphocytic leukemia (CLL)
Small lymphocytic lymphoma (SLL)
Disqualifiers
- -
Trial population
All patients with CLL/SLL or MBL diagnosis followed at participant sites starting from January 1st, 2010 (retrospective cohort) and from September 1st, 2021 (prospective cohort).
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Describe the diagnosis and management of CLL patients
evaluation of CLL management in terms of time to first treatment
Sponsors and contacts
Click on the lead sponsor to view all of their trials.